Literature DB >> 24655296

The aryl hydrocarbon receptor: multitasking in the immune system.

Brigitta Stockinger1, Paola Di Meglio, Manolis Gialitakis, João H Duarte.   

Abstract

The aryl hydrocarbon receptor (AhR), for many years almost exclusively studied by the pharmacology/toxicology field for its role in mediating the toxicity of xenobiotics such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), has more recently attracted the attention of immunologists. The evolutionary conservation of this transcription factor and its widespread expression in the immune system point to important physiological functions that are slowly being unraveled. In particular, the emphasis is now shifting from the role of AhR in the xenobiotic pathway toward its mode of action in response to physiological ligands. In this article, we review the current understanding of the molecular interactions and functions of AhR in the immune system in steady state and in the presence of infection and inflammation, with a focus on barrier organs such as the skin, the gut, and the lung.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24655296     DOI: 10.1146/annurev-immunol-032713-120245

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  321 in total

Review 1.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

2.  Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.

Authors:  Shiyang Li; Jennifer J Heller; John W Bostick; Aileen Lee; Hilde Schjerven; Philippe Kastner; Susan Chan; Zongming E Chen; Liang Zhou
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

3.  Mixed Vehicle Emissions Induces Angiotensin II and Cerebral Microvascular Angiotensin Receptor Expression in C57Bl/6 Mice and Promotes Alterations in Integrity in a Blood-Brain Barrier Coculture Model.

Authors:  Usa Suwannasual; JoAnn Lucero; Griffith Davis; Jacob D McDonald; Amie K Lund
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

4.  Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†.

Authors:  Yan Li; Chi Zhou; Wei Lei; Kai Wang; Jing Zheng
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

5.  Aryl hydrocarbon receptor gene transitions (c.-742C>T; c.1661G>A) and idiopathic male infertility: a case-control study with in silico and meta-analysis.

Authors:  Younes Aftabi; Abasalt Hosseinzadeh Colagar; Faramarz Mehrnejad; Ensiyeh Seyedrezazadeh; Emadoddin Moudi
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-15       Impact factor: 4.223

Review 6.  Control of immune-mediated pathology via the aryl hydrocarbon receptor.

Authors:  Michael A Wheeler; Veit Rothhammer; Francisco J Quintana
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 7.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 8.  Recent trends and future directions for the medical treatment of ulcerative colitis.

Authors:  Makoto Naganuma; Shinta Mizuno; Kosaku Nanki; Shinya Sugimoto; Takanori Kanai
Journal:  Clin J Gastroenterol       Date:  2016-10-03

9.  Proceedings of the 2018 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Vinicius Carreira; Caralyn S Labriola; Debabrata Mahapatra; Sean R McKeag; Matthias Rinke; Cynthia Shackelford; Bhanu Singh; Ashley Talley; Shannon M Wallace; Lyn M Wancket; Cynthia J Willson
Journal:  Toxicol Pathol       Date:  2018-10-03       Impact factor: 1.902

Review 10.  Hypoxia and Mucosal Inflammation.

Authors:  Sean P Colgan; Eric L Campbell; Douglas J Kominsky
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.